Zhen-Wang Zhao

1.2k total citations
36 papers, 907 citations indexed

About

Zhen-Wang Zhao is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhen-Wang Zhao has authored 36 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 17 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Zhen-Wang Zhao's work include Cholesterol and Lipid Metabolism (19 papers), Cancer, Lipids, and Metabolism (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Zhen-Wang Zhao is often cited by papers focused on Cholesterol and Lipid Metabolism (19 papers), Cancer, Lipids, and Metabolism (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Zhen-Wang Zhao collaborates with scholars based in China, Canada and United States. Zhen-Wang Zhao's co-authors include Chao‐Ke Tang, Xi‐Long Zheng, Duo Gong, Jin Zou, Xiao-Dan Xia, Xiao-Hua Yu, Gang Wang, Lingyan Chen, Dawei Zhang and Haipeng Cheng and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Lipid Research.

In The Last Decade

Zhen-Wang Zhao

34 papers receiving 899 citations

Peers

Zhen-Wang Zhao
Duo Gong China
Stephanie Marshall United States
Matthew M. Molusky United States
Calpurnia Jayakumar United States
Duo Gong China
Zhen-Wang Zhao
Citations per year, relative to Zhen-Wang Zhao Zhen-Wang Zhao (= 1×) peers Duo Gong

Countries citing papers authored by Zhen-Wang Zhao

Since Specialization
Citations

This map shows the geographic impact of Zhen-Wang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen-Wang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen-Wang Zhao more than expected).

Fields of papers citing papers by Zhen-Wang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen-Wang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen-Wang Zhao. The network helps show where Zhen-Wang Zhao may publish in the future.

Co-authorship network of co-authors of Zhen-Wang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen-Wang Zhao. A scholar is included among the top collaborators of Zhen-Wang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen-Wang Zhao. Zhen-Wang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ke, Zhen-Wang Zhao, Mingming Liu, et al.. (2025). TM9SF1 as a Novel Prognostic Biomarker for Sepsis Severity and Mortality: A Longitudinal Study. Journal of Inflammation Research. Volume 18. 11611–11626.
2.
Pan, Jing, et al.. (2025). Angiotensin II: A novel biomarker in vascular diseases. Clinica Chimica Acta. 568. 120154–120154. 3 indexed citations
3.
Xiao, Juan, Zhen-Wang Zhao, Jinsong Xiong, et al.. (2024). TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy. BMC Medicine. 22(1). 502–502. 4 indexed citations
4.
Xue, Zheng, Zhen-Wang Zhao, & Lidan Zhao. (2024). Investigating the Effect of an Anti-Inflammatory Drug in Determining NURR1 Expression and Thus Exploring the Progression of Parkinson's Disease. Physiological Research. 73(1/2024). 139–155.
5.
Zhang, Lu, Zhen-Wang Zhao, Xiaofang Shen, et al.. (2024). TM9SF1 offers utility as an efficient predictor of clinical severity and mortality among acute respiratory distress syndrome patients. Frontiers in Immunology. 15. 1408406–1408406. 2 indexed citations
6.
Zhao, Zhen-Wang, et al.. (2023). cGAS-STING-mediated inflammation and neurodegeneration as a strategy for the treatment of neurodegenerative diseases. Acta Biochimica et Biophysica Sinica. 56(1). 148–150. 3 indexed citations
7.
Zhu, Rongrong, et al.. (2023). The role of N-acetyltransferases in cancers. Gene. 892. 147866–147866. 7 indexed citations
8.
Zou, Jin, et al.. (2022). Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway. Journal of Translational Medicine. 20(1). 337–337. 38 indexed citations
9.
Zhao, Zhen-Wang, Min Zhang, Jin Zou, et al.. (2021). Long non-coding RNA PCA3 inhibits lipid accumulation and atherosclerosis through the miR-140-5p/RFX7/ABCA1 axis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(5). 158904–158904. 19 indexed citations
10.
Liu, Shangming, Jiahui Gao, Zhen-Wang Zhao, et al.. (2021). promotes ABCA1 expression and cholesterol efflux in THP-1-derived macrophages. Acta Biochimica et Biophysica Sinica. 53(1). 63–71. 6 indexed citations
11.
Ou, Xiang, Jiahui Gao, Xiao-Hua Yu, et al.. (2019). Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(2). 158535–158535. 29 indexed citations
12.
Gao, Jiahui, Xiao-Hua Yu, Zhen-Wang Zhao, et al.. (2019). CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway. Journal of Lipid Research. 60(12). 2020–2033. 44 indexed citations
13.
Xie, Wei, Liang Li, Duo Gong, et al.. (2019). Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo. Atherosclerosis. 289. 143–161. 10 indexed citations
14.
Li, Heng, Xiao-Dan Xia, Zhen-Wang Zhao, et al.. (2018). IL-8 negatively regulates ABCA1 expression and cholesterol efflux via upregulating miR-183 in THP-1 macrophage-derived foam cells. Cytokine. 122. 154385–154385. 24 indexed citations
15.
Zhang, Min, Guo-Jun Zhao, Feng Yao, et al.. (2018). AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE −/− mice. Atherosclerosis. 273. 122–130. 38 indexed citations
16.
Li, Conghui, Duo Gong, Lingyan Chen, et al.. (2017). Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. European Journal of Pharmacology. 811. 74–86. 52 indexed citations
17.
Zhang, Xin, Qiong Ye, Duo Gong, et al.. (2017). Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells. Acta Biochimica et Biophysica Sinica. 49(6). 530–540. 21 indexed citations
18.
19.
Yao, Yan, Xin Zhang, Haipeng Chen, et al.. (2016). MicroRNA-186 promotes macrophage lipid accumulation and secretion of pro-inflammatory cytokines by targeting cystathionine γ-lyase in THP-1 macrophages. Atherosclerosis. 250. 122–132. 36 indexed citations
20.
Gong, Duo, Haipeng Cheng, Wei Xie, et al.. (2016). Cystathionine γ-lyase(CSE)/hydrogen sulfide system is regulated by miR-216a and influences cholesterol efflux in macrophages via the PI3K/AKT/ABCA1 pathway. Biochemical and Biophysical Research Communications. 470(1). 107–116. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026